ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,696
Screening encounters
3,005
Diagnostic referrals
587
Outstanding pathways
233

Screening pathway

  1. Screening3,005Encounters
  2. Positive finding1,027Documented findings
  3. Referral587Diagnostic referrals
  4. Follow-up661Diagnostic visits
  5. Outcome354Resolved pathways

Stage totals use different units. Pending pathways: 233. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3232 · EXP-3232Synthetic · Site B

Full participant history through 2026-04-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-20
  4. · Diagnostic referral · EXP-3232-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Reached
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-3232-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-20

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2696 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0803 · Expanded synthetic participant 0803Site D — Community Engagement Programme
EXP-0811 · Expanded synthetic participant 0811Site C — Rural Outreach Programme
EXP-0812 · Expanded synthetic participant 0812Site E — Resource-Constrained Navigation Programme
EXP-0813 · Expanded synthetic participant 0813Site E — Resource-Constrained Navigation Programme
EXP-0816 · Expanded synthetic participant 0816Site B — Peri-Urban Access Programme
EXP-0821 · Expanded synthetic participant 0821Site C — Rural Outreach Programme
EXP-0825 · Expanded synthetic participant 0825Site C — Rural Outreach Programme
EXP-0828 · Expanded synthetic participant 0828Site B — Peri-Urban Access Programme
EXP-0831 · Expanded synthetic participant 0831Site C — Rural Outreach Programme
EXP-0835 · Expanded synthetic participant 0835Site A — Urban Referral Hub
EXP-0837 · Expanded synthetic participant 0837Site D — Community Engagement Programme
EXP-0838 · Expanded synthetic participant 0838Site B — Peri-Urban Access Programme
EXP-0840 · Expanded synthetic participant 0840Site D — Community Engagement Programme
EXP-0841 · Expanded synthetic participant 0841Site D — Community Engagement Programme
EXP-0843 · Expanded synthetic participant 0843Site D — Community Engagement Programme
EXP-0844 · Expanded synthetic participant 0844Site C — Rural Outreach Programme
EXP-0846 · Expanded synthetic participant 0846Site D — Community Engagement Programme
EXP-0847 · Expanded synthetic participant 0847Site C — Rural Outreach Programme
EXP-0849 · Expanded synthetic participant 0849Site D — Community Engagement Programme
EXP-0852 · Expanded synthetic participant 0852Site A — Urban Referral Hub
EXP-0855 · Expanded synthetic participant 0855Site D — Community Engagement Programme
EXP-0856 · Expanded synthetic participant 0856Site E — Resource-Constrained Navigation Programme
EXP-0857 · Expanded synthetic participant 0857Site B — Peri-Urban Access Programme
EXP-0859 · Expanded synthetic participant 0859Site B — Peri-Urban Access Programme
EXP-0861 · Expanded synthetic participant 0861Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1238
HPV DNA
1320
Cytology
447

Navigation activity

Barrier documented
495
Contact attempt
857
Navigation intervention
213
Diagnostic booking
719
Diagnostic visit
661

Documented barriers

Contact difficulty
161
Transport difficulty
151
Appointment coordination
183

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.